Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Rossini

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Rheumatology (Oxford, England)|September 1, 2021
Comment on: Association between environmental air pollution and rheumatoid arthritis flares: replyGiovanni Adami, Maurizio Rossini
Rheumatology (Oxford, England)|March 22, 2021
Response to Dr. Essouma regarding the article by Adami et alGiovanni Adami, Maurizio Rossini
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic reviewSilvano Adami, Luca Idolazzi, Maurizio Rossini
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2026
Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone lossFederico Aldegheri, Maurizio Rossini, Ombretta Viapiana
Clinical Rheumatology|January 24, 2020
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvementGiovanni Orsolini, Ilaria Bertoldi, Maurizio Rossini
Calcified Tissue International|June 11, 2013
Involvement of WNT/β-catenin signaling in the treatment of osteoporosisMaurizio Rossini, Davide Gatti, Silvano Adami
Endocrine|May 31, 2015
Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?Giovanni Targher, Maurizio Rossini, Amedeo Lonardo
Clinical Rheumatology|November 11, 2020
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based reviewRiccardo Bixio, Maurizio Rossini, Alessandro Giollo
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosisDavide Gatti, Maurizio Rossini, Ignazio Sblendorio, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
Rosiglitazone therapy is associated with major clinical improvements in a patient with fibrodysplasia ossificans progressivaDavide Gatti, Ombretta Viapiana, Maurizio Rossini, et al.
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Rheumatology (Oxford, England)|September 1, 2021
Comment on: Association between environmental air pollution and rheumatoid arthritis flares: replyGiovanni Adami, Maurizio Rossini
Rheumatology (Oxford, England)|March 22, 2021
Response to Dr. Essouma regarding the article by Adami et alGiovanni Adami, Maurizio Rossini
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic reviewSilvano Adami, Luca Idolazzi, Maurizio Rossini
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2026
Response to: Letter to the editor regarding: Real‑world rebound pattern of serum collagen type I C‑telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment‑induced bone lossFederico Aldegheri, Maurizio Rossini, Ombretta Viapiana
Clinical Rheumatology|January 24, 2020
Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvementGiovanni Orsolini, Ilaria Bertoldi, Maurizio Rossini
Calcified Tissue International|June 11, 2013
Involvement of WNT/β-catenin signaling in the treatment of osteoporosisMaurizio Rossini, Davide Gatti, Silvano Adami
Endocrine|May 31, 2015
Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?Giovanni Targher, Maurizio Rossini, Amedeo Lonardo
Clinical Rheumatology|November 11, 2020
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based reviewRiccardo Bixio, Maurizio Rossini, Alessandro Giollo
Expert Opinion on Drug Metabolism & Toxicology|April 30, 2013
Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosisDavide Gatti, Maurizio Rossini, Ignazio Sblendorio, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 26, 2009
Rosiglitazone therapy is associated with major clinical improvements in a patient with fibrodysplasia ossificans progressivaDavide Gatti, Ombretta Viapiana, Maurizio Rossini, et al.
Pageof 33